SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy
10.1158/0008-5472.CAN-13-0982
Saved in:
Main Authors: | Jung, Y., Abdel-Fatah, T.M.A., Chan, S.Y.T., Nolan, C.C., Green, A.R., Ellis, I.O., Li, L., Huang, B., Lu, J., Xu, B., Chen, L., Ma, R.Z., Zhang, M., Wang, J., Wu, Z., Zhu, T., Perry, J.K., Lobie, P.E., Liu, D.-X. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/109650 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma
by: Kannan, N., et al.
Published: (2014) -
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
by: Hou, L., et al.
Published: (2014) -
Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone
by: Zhu, T., et al.
Published: (2014) -
Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene
by: Zhang, X., et al.
Published: (2014) -
Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
by: Pandey, V, et al.
Published: (2020)